← Back to all funds
Sofinnova Partners
Submit feedbackVenture CapitalHealthcareIndustrialTechnologyEnergy & Environment
Pioneered European life sciences venture capital since 1972, focusing on company creation and early-stage investments in biotech and medtech. Notable exits include the acquisition of Ablynx by Sanofi and CoreValve by Medtronic.
€4B
AUM
7
Funds
80
Executives
11
Green Funds
Investment Profile
Investment Range
€100K - €30M
Focus
Early Stage
Geographies
Europe, USA
Assets (21 of 151)
13
Healthcare
4
Biopharmaceuticals
2
Biotech & Pharma
1
Environmental Services
1
ICT
| Asset | Status ↑ | Sector | HQ | Source | Entry Date |
|---|---|---|---|---|---|
| Current | Healthcare | Milan | Website | - | |
▶Alia Therapeutics | Current | Healthcare | Trento | Website | - |
▶BioClec | Current | Healthcare | Milan | Website | - |
▶BiovelocITA | Current | Healthcare | Milan | Website | - |
▶Borea Therapeutics | Current | Healthcare | Milan | Website | - |
▶Enthera Pharmaceuticals | Current | Healthcare | Milan | Website | - |
▶EOS | Current | Healthcare | Milan | Website | - |
| Current | Healthcare | Milan | Website | - | |
| Current | Biotech & Pharma | Turin | Website | - | |
| Current | Biotech & Pharma | Turin | Website | - | |
▶Metis Precision Medicine | Current | Biopharmaceuticals | Turin | Website | - |
▶NanoPhoria | Current | Healthcare | Milan | Website | - |
Showing 1–12 of 21 assets
Page 1 of 2